Ask your doctor about FABHALTA, a PNH treatment that can fit your lifestyle
FABHALTA is helping redefine the standard for paroxysmal nocturnal hemoglobinuria (PNH) treatment
The first and only oral treatment for adults with PNH taken without infusions or injections
Controls both types of hemolysis seen in PNH: intravascular hemolysis (IVH) and extravascular hemolysis (EVH)
The challenges of living with PNH are as unique as the disease itself, so we made a commercial just for you. If you've been saying you're "fine," check out what you might be missing.
What is the most important information I should know about FABHALTA?
FABHALTA is a medicine that affects part of your immune system and may lower your ability to fight infections.
FABHALTA increases your chance of getting serious infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b. These serious infections may quickly become life-threatening or fatal if not recognized and treated early.
You must complete or update your vaccinations against Streptococcus pneumoniae and Neisseria meningitidis at least 2 weeks before your first dose of FABHALTA.
Approved Use
What is FABHALTA? FABHALTA is a prescription medicine used to treat adults with paroxysmal nocturnal hemoglobinuria (PNH).
It is not known if FABHALTA is safe and effective in children.
